Prostate cancer: a brief history and the discovery of hormonal ablation treatment - PubMed

Affiliations

• PMID: 11371867

Prostate cancer: a brief history and the discovery of hormonal ablation treatment

B Lytton. J Urol. 2001 Jun.

Similar articles

• Re: Prostate cancer: a brief history and the discovery of hormonal ablation treatment.

  Schultheiss D, Machtens S. Schultheiss D, et al. J Urol. 2002 Apr;167(4):1801. J Urol. 2002. PMID: 11912427 No abstract available.

• Adenocarcinoma of the prostate gland.

  Boxer RJ. Boxer RJ. Urol Surv. 1977 Jun;27(3):75-94. Urol Surv. 1977. PMID: 331648 Review. No abstract available.

• A history of prostate cancer treatment.

  Denmeade SR, Isaacs JT. Denmeade SR, et al. Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801. Nat Rev Cancer. 2002. PMID: 12044015 Free PMC article. Review.

• The history of endocrine therapy of benign and malignant diseases of the prostate.

  Machtens S, Schultheiss D, Kuczyk M, Truss MC, Jonas U. Machtens S, et al. World J Urol. 2000 Jun;18(3):222-6. doi: 10.1007/s003450000120. World J Urol. 2000. PMID: 10926087

• On lust and rage - prostate cancer, vasectomy and virility in the aging male.

  Hodgson D. Hodgson D. Aging Male. 2009 Mar;12(1):1-4. doi: 10.1080/13685530902769976. Aging Male. 2009. PMID: 19326291 No abstract available.

Cited by

• AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.

  Sardar S, McNair CM, Ravindranath L, Chand SN, Yuan W, Bogdan D, Welti J, Sharp A, Ryan NK, Knudsen LA, Schiewer MJ, DeArment EG, Janas T, Su XA, Butler LM, de Bono JS, Frese K, Brooks N, Pegg N, Knudsen KE, Shafi AA. Sardar S, et al. Oncogene. 2024 Oct;43(43):3197-3213. doi: 10.1038/s41388-024-03148-4. Epub 2024 Sep 13. Oncogene. 2024. PMID: 39266679 Free PMC article.

• Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.

  Su WP, Sun LN, Yang SL, Zhao H, Zeng TY, Wu WZ, Wang D. Su WP, et al. J Biochem Mol Toxicol. 2018 May 2;32(7):e22158. doi: 10.1002/jbt.22158. Online ahead of print. J Biochem Mol Toxicol. 2018. PMID: 29719090 Free PMC article.

• The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis.

  Mei W, Lin X, Kapoor A, Gu Y, Zhao K, Tang D. Mei W, et al. Cancers (Basel). 2019 Mar 27;11(4):434. doi: 10.3390/cancers11040434. Cancers (Basel). 2019. PMID: 30934773 Free PMC article. Review.

• AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.

  Sardar S, McNair CM, Ravindranath L, Chand SN, Yuan W, Bogdan D, Welti J, Sharp A, Ryan NK, Schiewer MJ, DeArment EG, Janas T, Su XA, Butler LM, de Bono JS, Frese K, Brooks N, Pegg N, Knudsen KE, Shafi AA. Sardar S, et al. bioRxiv [Preprint]. 2024 May 7:2024.05.07.592966. doi: 10.1101/2024.05.07.592966. bioRxiv. 2024. PMID: 38766099 Free PMC article. Updated. Preprint.

• Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer.

  Ojo D, Lin X, Wong N, Gu Y, Tang D. Ojo D, et al. Cancers (Basel). 2015 Nov 18;7(4):2290-308. doi: 10.3390/cancers7040890. Cancers (Basel). 2015. PMID: 26593949 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information